Docking and QSAR analysis of tetracyclic oxindole derivatives as α-glucosidase inhibitors

被引:13
作者
Asadollahi-Baboli, M. [1 ]
Dehnavi, S. [1 ]
机构
[1] Babol Noshirvani Univ Technol, Dept Chem, Fac Sci, Babol Sar 4714871167, Mazandaran, Iran
关键词
alpha-Glucosidase inhibitors; Classification; Molecular docking; GA-PLS; SVM; Applicability domain; PROTEASE INHIBITORS; MOLECULAR DOCKING; MODELS; MLR; SET;
D O I
10.1016/j.compbiolchem.2018.07.019
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The alpha-glucosidase inhibitors are considered as important agents in drug discovery against diabetes mellitus. Molecular docking and quantitative structure-activity relationship (QSAR) were performed based on a series of tetracyclic oxindole derivatives to elucidate key structural properties affecting inhibitory activity and support the design of new alpha-glucosidase inhibitors. The molecular docking results demonstrate that at least two hydrogen bonds between Thr681 and Arg676 residues and the oxygen atoms in amid groups have an important role in the optimum binding of inhibitors. In addition, the sum of polar contacts of Arg699, Arg670, Glu792 and Glu301 residues with the alpha-glucosidase inhibitors have more than one third of total binding free energy. The docked conformations of the inhibitors with the best binding free energy were used to construct QSAR models. As a primary survey and a graphical comparing tool, the partial least squares-discriminant analysis (PLS-DA) technique was successfully employed to classify active and inactive inhibitors. The validated QSAR analysis were performed through genetic algorithm-partial least squares (GA-PLS) and support vector machine (SVM) techniques. The QSAR model reveals that important features of J3D, Mor26 u and HOMA have a high predictive capability (R-p(2) = 0.837, Q(LOO)(2) = 0.871, R-LSO(2) = 0.790 and r(m)(2) = 0.758) using GA-PLS/SVM strategy. Generally, the suggested QSAR analysis based on classification, docking and GA-PLS/SVM strategy may help suggest chemical scaffold to design novel oxindole derivatives as alpha-glucosidase inhibitors.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 22 条
  • [1] High-dimensional QSAR classification model for anti-hepatitis C virus activity of thiourea derivatives based on the sparse logistic regression model with a bridge penalty
    Algamal, Zakariya Yahya
    Lee, Muhammad Hisyam
    Al-Fakih, Abdo M.
    Aziz, Madzlan
    [J]. JOURNAL OF CHEMOMETRICS, 2017, 31 (06)
  • [2] [Anonymous], 2009, MOL DESCRIPTORS CHEM
  • [3] Molecular docking, molecular dynamics simulation, and QSAR model on potent thiazolidine-4-carboxylic acid inhibitors of influenza neuraminidase
    Asadollahi-Baboli, M.
    Mani-Varnosfaderani, A.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (04) : 1700 - 1710
  • [4] QSAR study using topological indices for inhibition of carbonic anhydrase II by sulfanilamides and Schiff bases
    Balaban, Alexandru T.
    Basak, Subhash C.
    Beteringhe, Adrian
    Mills, Denise
    Supuran, Claudiu T.
    [J]. MOLECULAR DIVERSITY, 2004, 8 (04) : 401 - 412
  • [5] A QSAR study of integrase strand transfer inhibitors based on a large set of pyrimidine, pyrimidone, and pyridopyrazine carboxamide derivatives
    de Campos, Luana Janaina
    de Melo, Eduardo Borges
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2017, 1141 : 252 - 260
  • [6] Exploring QSARs for Inhibitory Activity of Non-peptide HIV-1 Protease Inhibitors by GA-PLS and GA-SVM
    Deeb, Omar
    Goodarzi, Mohammad
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (05) : 506 - 514
  • [7] α-Glucosidase inhibitors and their use in clinical practice
    Derosa, Giuseppe
    Maffioli, Pamela
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (05) : 899 - 906
  • [8] 3D-MoRSE descriptors explained
    Devinyak, Oleg
    Havrylyuk, Dmytro
    Lesyk, Roman
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2014, 54 : 194 - 203
  • [9] Principles of QSAR models validation: internal and external
    Gramatica, Paola
    [J]. QSAR & COMBINATORIAL SCIENCE, 2007, 26 (05): : 694 - 701
  • [10] Global estimates of diabetes prevalence for 2013 and projections for 2035
    Guariguata, L.
    Whiting, D. R.
    Hambleton, I.
    Beagley, J.
    Linnenkamp, U.
    Shaw, J. E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) : 137 - 149